Subscribe to RSS - ResMed

ResMed

ResMed boasts double-digit growth, with ‘more runway ahead’

 - 
01/23/2018

SAN DIEGO – ResMed on Jan. 22 reported revenues of $601.3 million for the second quarter of fiscal year 2018, a 13% increased compared to the same quarter last year. Revenues in the U.S., Canada and Latin America, excluding Brightree, were $329.2 million, a 12% increase.

ResMed debuts Mobi

 - 
01/09/2018

SAN FRANCISCO – ResMed has formally introduced its first portable oxygen concentrator to the market. The company says Mobi will be available to U.S. patients through their HME providers later this quarter, and it is pursuing clearance to sell in other countries in 2018.

Study: Hospitals can help diagnose sleep apnea

 - 
01/03/2018

SAN DIEGO – A ResMed-funded study makes the case for hospitals screening patients for sleep apnea before they’re discharged to improve their chances of long-term survival.

ResMed named top corporate citizen

 - 
12/13/2017

SAN DIEGO – ResMed has been named one of America’s top 100 corporate citizens for the second straight year by Forbes and JUST Capital, a nonprofit that analyzes and ranks companies based on how they serve the priorities of the American people. ResMed ranked No.

F&P files lawsuit in Australia

 - 
12/12/2017

AUCKLAND, New Zealand – Fisher & Paykel Healthcare filed patent infringement proceedings against ResMed in the Federal Court of Australia on Dec.

ResMed named finalist

 - 
12/06/2017

SAN DIEGO – ResMed has been named a finalist for “Medtech Company of the Year” by MD+DI, a news resource in the medical device and diagnostic industry.

In brief: MedPAC recommends CMS shift more products into bid program, AmerisourceBergen buys H.D. Smith

 - 
11/20/2017

WASHINGTON – The Medicare Payment Advisory Committee made payment policy recommendations for non-competitively bid DMEPOS during a meeting earlier this month, according to Epstein Becker & Green, a healthcare law firm.

In brief: Inconsistencies in bid program, Trump’s new HHS nominee

 - 
11/16/2017

BALTIMORE – CMS did not always follow its own procedures and federal requirements for awarding competitive bidding contracts consistently, according to a new report from the Office of Inspector General.

ResMed announces board change

 - 
11/17/2017

SAN DIEGO – ResMed has named Karen Drexler to its board of directors, the company has announced. Drexler is CEO and board member of Bay area biotech company Sandstone Diagnostics, and has extensive healthcare management experience.

F&P wins patent case in UK

 - 
11/14/2017

AUCKLAND, New Zealand – The English Patents Court has sided with Fisher & Paykel Healthcare, saying a ResMed patent for masks is invalid in the U.K.

Pages